Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
424,966,351
-
Total 13F shares
-
320,707,173
-
Share change
-
+6,055,853
-
Total reported value
-
$8,183,523,072
-
Put/Call ratio
-
23%
-
Price per share
-
$25.51
-
Number of holders
-
414
-
Value change
-
+$144,649,409
-
Number of buys
-
214
-
Number of sells
-
185
Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q4 2024
As of 31 Dec 2024,
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by
414 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
320,707,173 shares.
The largest 10 holders included
MORGAN STANLEY, VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., BAILLIE GIFFORD & CO, VIKING GLOBAL INVESTORS LP, Swedbank AB, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
414
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.